Mersana Therapeutics, Inc. (MRSN)
NASDAQ: MRSN · Real-Time Price · USD
1.980
-0.240 (-10.81%)
At close: Nov 21, 2024, 4:00 PM
2.000
+0.020 (1.01%)
After-hours: Nov 21, 2024, 5:42 PM EST
Mersana Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -74.62 | -171.67 | -204.21 | -170.06 | -88.05 | -28.21 | |
| Depreciation & Amortization | 1.68 | 1.52 | 0.93 | 0.86 | 1.01 | 1.25 | |
| Loss (Gain) From Sale of Investments | -3.67 | -4.57 | -1.46 | - | -0.09 | -0.22 | |
| Stock-Based Compensation | 17.2 | 21.14 | 21.52 | 18.41 | 7.17 | 4.87 | |
| Other Operating Activities | 3.41 | 3.47 | 3.54 | 2.55 | 0.15 | 0.1 | |
| Change in Accounts Receivable | -1 | 30 | -30 | - | - | 0.46 | |
| Change in Accounts Payable | -10.58 | -6.08 | 0.95 | 0.48 | 0.94 | -3.11 | |
| Change in Unearned Revenue | -17.86 | -22.14 | 143.71 | -0.04 | -0.83 | -41.38 | |
| Change in Other Net Operating Assets | -9.62 | -20.54 | 15.67 | 7.82 | 4.99 | -1.5 | |
| Operating Cash Flow | -95.05 | -168.88 | -49.36 | -139.99 | -74.7 | -67.74 | |
| Capital Expenditures | -0.52 | -2.17 | -2.2 | -0.65 | -0.47 | -0.61 | |
| Investment in Securities | -17.9 | 122.05 | -150.52 | - | 37.5 | -26.69 | |
| Investing Cash Flow | -18.42 | 119.88 | -152.72 | -0.65 | 37.03 | -27.29 | |
| Long-Term Debt Issued | - | - | - | 24.04 | - | 4.97 | |
| Long-Term Debt Repaid | - | -0.26 | -0.27 | -5.7 | -0.12 | -0.09 | |
| Net Debt Issued (Repaid) | -0.2 | -0.26 | -0.27 | 18.34 | -0.12 | 4.88 | |
| Issuance of Common Stock | 6.25 | 95.09 | 153.29 | 45.56 | 230.73 | 92.83 | |
| Repurchase of Common Stock | - | - | - | -0.26 | - | - | |
| Other Financing Activities | - | -0.15 | - | - | -0.2 | - | |
| Financing Cash Flow | 6.05 | 94.68 | 153.02 | 63.65 | 230.41 | 97.7 | |
| Net Cash Flow | -107.42 | 45.68 | -49.06 | -76.99 | 192.74 | 2.67 | |
| Free Cash Flow | -95.57 | -171.05 | -51.56 | -140.64 | -75.17 | -68.35 | |
| Free Cash Flow Margin | -274.33% | -464.12% | -193.97% | -327060.47% | -9078.38% | -162.26% | |
| Free Cash Flow Per Share | -0.78 | -1.47 | -0.55 | -1.99 | -1.22 | -1.57 | |
| Cash Interest Paid | 3.5 | 3.38 | 2.46 | 0.43 | 0.23 | 0.13 | |
| Levered Free Cash Flow | -42.16 | -85.71 | -93.22 | -78.67 | -42.16 | -59.2 | |
| Unlevered Free Cash Flow | -39.64 | -83.17 | -91.14 | -77.88 | -41.93 | -59.05 | |
| Change in Net Working Capital | 8.34 | -3.2 | -15.96 | -9.04 | -5.43 | 45.69 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.